AlzChem Group AG (ETR:ACT)

Germany · Delayed Price · Currency is EUR

161.80

-3.00 (-1.82%)

At close: Mar 27, 2026

66.12% (1Y)

Market Cap	1.64B +55.9%
Revenue (ttm)	575.05M +2.1%
Net Income	63.46M +17.4%
EPS	6.28 +18.1%
Shares Out	10.12M
PE Ratio	25.77
Forward PE	24.89
Dividend	2.10 (1.27%)
Ex-Dividend Date	May 6, 2026

Volume	18,752
Average Volume	28,532
Open	166.00
Previous Close	164.80
Day's Range	160.00 - 166.00
52-Week Range	73.70 - 179.40
Beta	0.58
RSI	49.78
Earnings Date	Feb 27, 2026

About AlzChem Group AG

AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This segment manufactures composite materials and adhesives, as well as silico... [Read more]

Industry Specialty Chemicals

Sector Materials

Founded 1908

Employees 1,794

Stock Exchange Deutsche Börse Xetra

Ticker Symbol ACT

Full Company Profile

Financial Performance

In 2025, AlzChem Group AG's revenue was 575.05 million, an increase of 2.06% compared to the previous year's 563.44 million. Earnings were 63.46 million, an increase of 17.35%.

Financial Statements